OPENGRID$1.2B+18.4%FORMA AISeries C$84MHALOWORKSIPO FiledS-1NORTHBEAM$220M+6.1%VANTABASE$36MSeed IIPARALLELAcquiredOBSIDIAN PROTOCOL$410M+22.0%GRAYMATTER$12MSeedSTACKHOUSEPublic+4.2%OPENGRID$1.2B+18.4%FORMA AISeries C$84MHALOWORKSIPO FiledS-1NORTHBEAM$220M+6.1%VANTABASE$36MSeed IIPARALLELAcquiredOBSIDIAN PROTOCOL$410M+22.0%GRAYMATTER$12MSeedSTACKHOUSEPublic+4.2%

Editorial's Best

The pieces we're proudest of

Audits, frameworks, and field reports. Every piece here is grounded in real primary sources and reviewed end-to-end by a human editor before publication. Start anywhere — they cluster around AI, business, and the practice of building software.

The full slate

  1. 04
    AI5 min read

    After the AI Bubble: An Audit of 2025's Promises

    We graded the public predictions. Most failed. A few quietly came true.

  2. 05
    AI5 min read

    The Small Model Renaissance: When Big AI Doesn't Win

    Frontier scale is still the story at the top. Everything below the top looks different now.

  3. 06
    AI5 min read

    The Five-Layer Cake of Modern AI Infrastructure

    A reference framework for thinking about the AI stack — silicon to application.

  4. 07
    Business5 min read

    The Rule of 40 Is Dead: What SaaS Boards Actually Look At in 2026

    The old rule was a single number. The new frameworks are messier and better.

  5. 08
    Startups5 min read

    The Founder's Vesting Cliff: A Field Guide

    Cliffs, double-trigger acceleration, taxes, and the edges that surprise people.

  6. 09
    Marketing5 min read

    The Quiet Death of Third-Party Cookies — and What Replaced Them

    A practitioner's guide to the post-cookie web for marketers and builders.

  7. 10
    Design5 min read

    The State of Design Systems in 2026: A Field Report

    Tokens won. Component libraries commoditized. The interesting work moved up the stack.

  8. 11
    Cybersecurity5 min read

    Zero-Trust in Production: A 2026 Field Guide

    The architecture works. The implementations are where the failures live.

  9. 12
    Science5 min read

    GLP-1 Drugs at Two Years: A Public Health Audit

    Ozempic, Wegovy, Mounjaro. What the data actually shows so far.

  10. 13
    Business5 min read

    How the $370B IRA Bet Is Actually Performing

    Three years in, the largest US climate investment in history meets its data.